Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 15Ovarian Neoplasms 9Recurrence 3Multiple Myeloma 3Lymphoma, Large B-Cell, Diffuse 3Neoplasms 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Non-Hodgkin 2Carcinoma, Ovarian Epithelial 2Uterine Cervical Neoplasms 1Unrecognized Condition 1Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasm Epithelial 1Muscle Invasive Bladder Cancer 1Mesothelioma, Malignant 1Lymphoma, Mantle-Cell 1Lymphoma 1Leukemia, Plasma Cell 1Hodgkin Disease 1HER2-positive Breast Cancer 1Genetic Predisposition to Disease 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Advanced Solid Tumors 1Advanced Breast Cancer 1

Interventions

Injections 4Paclitaxel 2toripalimab 1tesetaxel 1sintilimab 1satraplatin 1pembrolizumab 1liposomal doxorubicin 1isophosphamide mustard 1fluzoparib 1duvelisib 1camrelizumab 1apatinib 1anlotinib 1Vinorelbine 1Sirolimus 1Saline Solution 1SKLB1028 1Radiotherapy 1Panobinostat 1Lenalidomide 1Irinotecan 1Everolimus 1Docetaxel 1Carboplatin 1Biomarkers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Advanced Solid Tumors × liposomal doxorubicin × Clear all
NCT01148628 2011-09-13

Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors

Southern Europe New Drug Organization

Phase 1 Unknown
54 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡